Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs

por Henjes, F, Bender, C, von der Heyde, S, Braun, L, Mannsperger, H A, Schmidt, C, Wiemann, S, Hasmann, M, Aulmann, S, Beissbarth, T, Korf, U
Publicado 2012